Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Pinky Agarwal, Sudeshna Ray, Daniel Burdick, Alida F Griffith & Arina Madan. (2018) Efficacy and safety of ADS-5102 (amantadine) extended-release capsules for treating levodopa-induced dyskinesia. Expert Opinion on Orphan Drugs 6:10, pages 625-634.
Read now
Read now
Sanja Kovacic, Sinisa Roginic, Johann Nemrava, Ksenija Gospocic, Maida Seferovic Saric & Kresimir Luetic. (2017) Acute pancreatitis in two patients with Parkinson’s disease. Cogent Medicine 4:1.
Read now
Read now
Livia Dézsi & László Vécsei. (2014) Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs. Expert Opinion on Drug Metabolism & Toxicology 10:3, pages 409-424.
Read now
Read now
Heinz Reichmann & Murat Emre. (2012) Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson’s disease: focus on levodopa/carbidopa/entacapone. Expert Review of Neurotherapeutics 12:2, pages 119-131.
Read now
Read now
Werner Poewe, Angelo Antonini, Jan CM Zijlmans, Pierre R Burkhard & François Vingerhoets. (2010) Levodopa in the treatment of Parkinson’s disease: an old drug still going strong. Clinical Interventions in Aging 5, pages 229-238.
Read now
Read now
Antonio Di Stefano, Piera Sozio, Antonio Iannitelli & Laura Serafina Cerasa. (2009) New drug delivery strategies for improved Parkinson's disease therapy. Expert Opinion on Drug Delivery 6:4, pages 389-404.
Read now
Read now
Articles from other publishers (74)
Valentina Leta, Lisa Klingelhoefer, Katherine Longardner, Marta Campagnolo, Hafize Çotur Levent, Federico Aureli, Vinod Metta, Roongroj Bhidayasiri, Guy Chung‐Faye, Cristian Falup‐Pecurariu, Fabrizio Stocchi, Peter Jenner, Tobias Warnecke & K. Ray Chaudhuri. (2023) Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease. European Journal of Neurology 30:5, pages 1465-1480.
Crossref
Crossref
Kara R. Grimes, Abhilasha Aloney, Dimitra Skondra & Jay Chhablani. (2023) Effects of systemic drugs on the development and progression of age-related macular degeneration. Survey of Ophthalmology 68:3, pages 332-346.
Crossref
Crossref
Jihong Gong, Ziqi Jin, Huidan Chen, Juan He, Yiran Zhang & Xiaofei Yang. (2023) Super-resolution fluorescence microscopic imaging in pathogenesis and drug treatment of neurological disease. Advanced Drug Delivery Reviews 196, pages 114791.
Crossref
Crossref
Alfonso Fasano, Rocío García-Ramos, Tanya Gurevich, Robert Jech, Lars Bergmann, Olga Sanchez-Soliño, Juan Carlos Parra & Mihaela Simu. (2023) Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS. Journal of Neurology 270:5, pages 2765-2775.
Crossref
Crossref
Matt Baucum, Anahita Khojandi, Rama Vasudevan & Ritesh Ramdhani. (2023) Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson’s Disease. Management Science.
Crossref
Crossref
Mohammad R. Salmanpour, Mahdi Hosseinzadeh, Mahya Bakhtiyari, Mehdi Maghsudi & Arman Rahmim. (2023) Prediction of drug amount in Parkinson's disease using hybrid machine learning systems and radiomics features. International Journal of Imaging Systems and Technology.
Crossref
Crossref
Ruben K. Dagda, Raul Y. Dagda, Emmanuel Vazquez-Mayorga, Bridget Martinez & Aine Gallahue. (2022) Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats. International Journal of Molecular Sciences 24:1, pages 690.
Crossref
Crossref
Sun Ju Chung, Matilde Calopa, Maria G. Ceravolo, Nicola Tambasco, Angelo Antonini, K. Ray Chaudhuri, Weining Z. Robieson, Olga Sánchez-Soliño, Cindy Zadikoff, Man Jin & Luigi M. Barbato. (2022) Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study. Parkinson's Disease 2022, pages 1-10.
Crossref
Crossref
Joaquim J. Ferreira, Werner Poewe, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, Joana Moreira, Bruno Guimarães, José‐Francisco Rocha & Patrício Soares‐da‐Silva. (2022) Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease. Movement Disorders 37:11, pages 2272-2283.
Crossref
Crossref
Thuy Trang Nguyen, Nguyen Si Bao & Giau Van Vo. (2022) Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease. Neurochemical Research 47:8, pages 2129-2141.
Crossref
Crossref
Prashanna Khwaounjoo, Gurleen Singh, Sophie Grenfell, Burak Özsoy, Michael R. MacAskill, Tim J. Anderson & Yusuf O. Çakmak. (2022) Non-Contact Hand Movement Analysis for Optimal Configuration of Smart Sensors to Capture Parkinson’s Disease Hand Tremor. Sensors 22:12, pages 4613.
Crossref
Crossref
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit K. Kukreja, Koray Onuk, Lars Bergmann, James Pike & K. Ray Chaudhuri. (2022) Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurology and Therapy 11:1, pages 303-318.
Crossref
Crossref
Matthew Bernardinis, S. Farokh Atashzar, Rajni V. Patel & Mandar S. Jog. (2021) Abnormal Vision-Based Displacement Perception in Parkinson’s Disease. Frontiers in Neuroscience 15.
Crossref
Crossref
Shaoping Hou, Jaclyn H. DeFinis, Stephanie L. Daugherty, Chuanxi Tang, Jeremy Weinberger & William C. de Groat. (2021) Deciphering Spinal Endogenous Dopaminergic Mechanisms That Modulate Micturition Reflexes in Rats with Spinal Cord Injury. eneuro 8:4, pages ENEURO.0157-21.2021.
Crossref
Crossref
Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock & Mark B. Carlton. (2021) Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics 377:3, pages 407-416.
Crossref
Crossref
Angelo Antonini, Per Odin, Rajesh Pahwa, Jason Aldred, Ali Alobaidi, Yash J. Jalundhwala, Pavnit Kukreja, Lars Bergmann, Sushmitha Inguva, Yanjun Bao & K. Ray Chaudhuri. (2021) The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review. Advances in Therapy 38:6, pages 2854-2890.
Crossref
Crossref
Dario Breitel, Paul Brett, Saleh Alseekh, Alisdair R. Fernie, Eugenio Butelli & Cathie Martin. (2021) Metabolic engineering of tomato fruit enriched in L-DOPA. Metabolic Engineering 65, pages 185-196.
Crossref
Crossref
Rob Powers, Maryam Etezadi-AmoliEdith M. ArnoldSara Kianian, Irida ManceMaxsim Gibiansky, Dan TrietschAlexander Singh AlvaradoJames D. KretlowTodd M. Herrington, Salima Brillman, Nengchun HuangPeter T. Lin, Hung A. PhamAdeeti V. Ullal. (2021) Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease. Science Translational Medicine 13:579.
Crossref
Crossref
Tomasz Gutowski & Mariusz Chmielewski. (2021) An Algorithmic Approach for Quantitative Evaluation of Parkinson’s Disease Symptoms and Medical Treatment Utilizing Wearables and Multi-Criteria Symptoms Assessment. IEEE Access 9, pages 24133-24144.
Crossref
Crossref
Mickey E. Abraham, Justin Gold, Akhil Dondapati, Julian Gendreau, Antonios Mammis & Yehuda Herschman. (2021) Intrathecal and intracerebroventricular dopamine for Parkinson’s disease. Clinical Neurology and Neurosurgery 200, pages 106374.
Crossref
Crossref
Hazhir Teymourian, Marc Parrilla, Juliane R. Sempionatto, Noelia Felipe Montiel, Abbas Barfidokht, Robin Van Echelpoel, Karolien De Wael & Joseph Wang. (2020) Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs. ACS Sensors 5:9, pages 2679-2700.
Crossref
Crossref
Florence Véronneau-Veilleux, Mauro Ursino, Philippe Robaey, Daniel Lévesque & Fahima Nekka. (2020) Nonlinear pharmacodynamics of levodopa through Parkinson’s disease progression. Chaos: An Interdisciplinary Journal of Nonlinear Science 30:9, pages 093146.
Crossref
Crossref
Xiaoli Liao, Nianyue Wu, Dongfeng Liu, Bowei Shuai, Shilei Li & Ke Li. (2020) Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: a meta-analysis. Neurological Sciences 41:8, pages 2045-2054.
Crossref
Crossref
R E Sardjono, A N Fauziyah, M D Puspitasari, I Musthapa, F Khoerunnisa, G N Azzahra, R Mamat & Erdiwansyah. (2020) Synthesis and antiparkinsonian activity of nanocomposite of chitosan-tripolyphosphate-Mucuna pruriens L extract (CS-TPP-MP). IOP Conference Series: Materials Science and Engineering 856:1, pages 012009.
Crossref
Crossref
Cindy Zadikoff, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh & Angelo Antonini. (2020) Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa. Parkinson's Disease 2020, pages 1-11.
Crossref
Crossref
Christian Harito, Listya Utari, Budi Riza Putra, Brian Yuliarto, Setyo Purwanto, Syed Z. J. Zaidi, Dmitry V. Bavykin, Frank Marken & Frank C. Walsh. (2020) Review—The Development of Wearable Polymer-Based Sensors: Perspectives. Journal of The Electrochemical Society 167:3, pages 037566.
Crossref
Crossref
Iman M. Higazy. (2020) Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s. Saudi Pharmaceutical Journal 28:1, pages 33-57.
Crossref
Crossref
Meichen Liu, Shiting Yu, Jiawen Wang, Juhui Qiao, Ying Liu, Siming Wang & Yu Zhao. (2020) Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease. Journal of Ethnopharmacology 247, pages 112213.
Crossref
Crossref
M.P. Sooraj, Archana S. Nair, Suresh C. Pillai, Steven J. Hinder & Beena Mathew. (2020) CuNPs decorated molecular imprinted polymer on MWCNT for the electrochemical detection of l-DOPA. Arabian Journal of Chemistry 13:1, pages 2483-2495.
Crossref
Crossref
Congcong Sun, Wenfei Yu, Zhenxiang Zhao, Chengyuan Song, Ying Liu, Guoyong Jia, Xingbang Wang & Yiming Liu. (2019) Peripheral Humoral Immune Response Is Associated With the Non-motor Symptoms of Parkinson’s Disease. Frontiers in Neuroscience 13.
Crossref
Crossref
Margarita Gómez-Chavarín, Gina Prado-Prone, Patricia Padilla, Jesús Ramírez Santos, Gabriel Gutiérrez-Ospina & Jorge A. García-Macedo. (2019)
Dopamine Released from TiO
2
Semicrystalline Lattice Implants Attenuates Motor Symptoms in Rats Treated with 6-Hydroxydopamine
. ACS Omega 4:5, pages 7953-7962.
Crossref
Crossref
Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith & Jon T. Njardarson. (2018) A Survey of the Structures of US FDA Approved Combination Drugs. Journal of Medicinal Chemistry 62:9, pages 4265-4311.
Crossref
Crossref
John P. M. Finberg. (2018) Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease. Journal of Neural Transmission 126:4, pages 433-448.
Crossref
Crossref
Ana Puga, Sara Lopez-Oliva, Carmen Trives, Teresa Partearroyo & Gregorio Varela-Moreiras. (2019) Effects of Drugs and Excipients on Hydration Status. Nutrients 11:3, pages 669.
Crossref
Crossref
Sara Lorio, Fabio Sambataro, Alessandro Bertolino, Bogdan Draganski & Juergen Dukart. (2019) The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Taegyo Kim, Robert A. Capps, Khaldoun C. Hamade, William H. Barnett, Dmitrii I. Todorov, Elizaveta M. Latash, Sergey N. Markin, Ilya A. Rybak & Yaroslav I. Molkov. (2019) The Functional Role of Striatal Cholinergic Interneurons in Reinforcement Learning From Computational Perspective. Frontiers in Neural Circuits 13.
Crossref
Crossref
Stalin Kondaveeti, Ana Teresa Silva Semeano, Daniel R. Cornejo, Henning Ulrich & Denise Freitas Siqueira Petri. (2018) Magnetic hydrogels for levodopa release and cell stimulation triggered by external magnetic field. Colloids and Surfaces B: Biointerfaces 167, pages 415-424.
Crossref
Crossref
Jong-Suep Baek, Jie Kai Tee, Yi Yun Pang, Ern Yu Tan, Kah Leong Lim, Han Kiat Ho & Say Chye Joachim Loo. (2018) Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson’s Disease. NeuroMolecular Medicine 20:2, pages 262-270.
Crossref
Crossref
Laura L. Pitts, Sarah Morales & Julie A. G. Stierwalt. (2018) Lingual Pressure as a Clinical Indicator of Swallowing Function in Parkinson's Disease. Journal of Speech, Language, and Hearing Research 61:2, pages 257-265.
Crossref
Crossref
Ratnaningsih Eko Sardjono, Fitri Khoerunnisa, Iqbal Musthopa, Dinar Khairunisa, Putri Astuti Suganda & Rahmi Rachmawati. (2018)
Synthesize of zinc nanoparticles using Indonesian velvet bean (
Mucuna pruriens
) extract and evaluate its potency in lowering catalepsy in mice
. IOP Conference Series: Materials Science and Engineering 299, pages 012080.
Crossref
Crossref
Jae Woo Chung, Roxana G. Burciu, Edward Ofori, Stephen A. Coombes, Evangelos A. Christou, Michael S. Okun, Christopher W. Hess & David E. Vaillancourt. (2018) Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia. NeuroImage: Clinical 19, pages 559-571.
Crossref
Crossref
Vanessa Azzopardi, Matthew Guy & Emma Lewis. 2018. Medical Image Understanding and Analysis. Medical Image Understanding and Analysis
94
105
.
Valeria P. Alanis, Hiram A. Cantú, Umberto León, Alejandro Melo, Julio C. Salinas, Diego Velasco & Jorge de-J. Lozoya-Santos. 2018. Smart Technology. Smart Technology
199
208
.
Fatma Haddad, Maryam Sawalha, Yahya Khawaja, Anas Najjar & Rafik Karaman. (2017) Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease. Molecules 23:1, pages 40.
Crossref
Crossref
Loredana Leggio, Silvia Vivarelli, Francesca L’Episcopo, Cataldo Tirolo, Salvo Caniglia, Nunzio Testa, Bianca Marchetti & Nunzio Iraci. (2017) microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 18:12, pages 2698.
Crossref
Crossref
Amina M. Bagher, Robert B. Laprairie, J. Thomas Toguri, Melanie E.M. Kelly & Eileen M. Denovan-Wright. (2017) Bidirectional allosteric interactions between cannabinoid receptor 1 (CB 1 ) and dopamine receptor 2 long (D 2L ) heterotetramers. European Journal of Pharmacology 813, pages 66-83.
Crossref
Crossref
Jue Wang, Sheng Luo & Liang Li. (2017) Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease. The Annals of Applied Statistics 11:3.
Crossref
Crossref
Teresa Arroyo-Gallego, Maria Jesus Ledesma-Carbayo, Alvaro Sanchez-Ferro, Ian Butterworth, Carlos S. Mendoza, Michele Matarazzo, Paloma Montero, Roberto Lopez-Blanco, Veronica Puertas-Martin, Rocio Trincado & Luca Giancardo. (2017) Detection of Motor Impairment in Parkinson's Disease Via Mobile Touchscreen Typing. IEEE Transactions on Biomedical Engineering 64:9, pages 1994-2002.
Crossref
Crossref
C. Pellegrini, L. Antonioli, R. Colucci, E. Tirotta, D. Gentile, C. Ippolito, C. Segnani, G. Levandis, S. Cerri, F. Blandini, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi & M. Fornai. (2017) Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration. Neuropharmacology 123, pages 22-33.
Crossref
Crossref
Fung Kei Cheng. (2017) The use of acupuncture in patients with Parkinson's disease. Geriatric Nursing 38:4, pages 302-314.
Crossref
Crossref
Anindita Chowdhury, Selvaraj Kunjiappan, Theivendren Panneerselvam, Balasubramanian Somasundaram & Chiranjib Bhattacharjee. (2017) Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. International Nano Letters 7:2, pages 91-122.
Crossref
Crossref
Yang Chen & Rong Xu. (2017) Context-sensitive network-based disease genetics prediction and its implications in drug discovery. Bioinformatics 33:7, pages 1031-1039.
Crossref
Crossref
Jae Woo Chung, Roxana G. Burciu, Edward Ofori, Priyank Shukla, Michael S. Okun, Christopher W. Hess & David E. Vaillancourt. (2017) Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication. NeuroImage: Clinical 14, pages 417-421.
Crossref
Crossref
Marcia Cristina Teixeira dos Santos, Rosie Bell & Andre Nogueira da Costa. (2016) Recent developments in circulating biomarkers in Parkinson’s disease: the potential use of miRNAs in a clinical setting. Bioanalysis 8:23, pages 2497-2518.
Crossref
Crossref
Jong-Suep Baek, Chee Chong Choo, Cheng Qian, Nguan Soon Tan, Zexiang Shen & Say Chye Joachim Loo. (2016) Multi-Drug-Loaded Microcapsules with Controlled Release for Management of Parkinson's Disease. Small 12:27, pages 3712-3722.
Crossref
Crossref
Marouen Ben Guebila & Ines Thiele. (2016) Model-based dietary optimization for late-stage, levodopa-treated, Parkinson’s disease patients. npj Systems Biology and Applications 2:1.
Crossref
Crossref
Liping Huang, Minzhen Deng, Yuping He, Shiyao Lu, Ruanxin Ma & Yongqi Fang. (2016)
β
-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain
. Clinical and Experimental Pharmacology and Physiology 43:6, pages 634-643.
Crossref
Crossref
Aline Aparecida Foppa, Clarice Chemello, Claudia Marcela Vargas-Peláez & Mareni Rocha Farias. (2016) Medication Therapy Management Service for Patients with Parkinson’s Disease: A Before-and-After Study. Neurology and Therapy 5:1, pages 85-99.
Crossref
Crossref
Grant Gibson. (2016) ‘Signposts on the journey’; medication adherence and the lived body in men with Parkinson's disease. Social Science & Medicine 152, pages 27-34.
Crossref
Crossref
Gerrit E Gmel, Tara J Hamilton, Milan Obradovic, Robert B Gorman, Peter S Single, Helen J Chenery, Terry Coyne, Peter A Silburn & John L Parker. (2015) A new biomarker for subthalamic deep brain stimulation for patients with advanced Parkinson’s disease—a pilot study. Journal of Neural Engineering 12:6, pages 066013.
Crossref
Crossref
Kristoffer Laumann, Ulrik Boas, Hjalte M. Larsen, Peter M. H. Heegaard & Ann-Louise Bergström. (2014) Urea and Thiourea Modified Polypropyleneimine Dendrimers Clear Intracellular α-Synuclein Aggregates in a Human Cell Line. Biomacromolecules 16:1, pages 116-124.
Crossref
Crossref
R. L. M. Jansen, B. Brogan, A. J. Whitworth & E. J. Okello. (2014)
Effects of Five Ayurvedic Herbs on Locomotor Behaviour in a
Drosophila melanogaster
Parkinson's Disease Model
. Phytotherapy Research 28:12, pages 1789-1795.
Crossref
Crossref
Marquitta L. Smith, Jennifer King, Lemuel Dent, Veronica Mackey, Gladson Muthian, Brenya Griffin & Clivel G. Charlton. (2014) Effects of acute and sub-chronic l-dopa therapy on striatal l-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease. Life Sciences 110:1, pages 1-7.
Crossref
Crossref
P. Martínez-Martín, B. Hernández & J. Ricart. (2014) Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease. Neurología (English Edition) 29:3, pages 153-160.
Crossref
Crossref
P. Martínez-Martín, B. Hernández & J. Ricart. (2014) Factores determinantes del inicio de tratamiento con levodopa/carbidopa/entacapona en pacientes españoles con enfermedad de Parkinson. Neurología 29:3, pages 153-160.
Crossref
Crossref
Eduardo Tolosa, Basilio Hernández, Gurutz Linazasoro, Juan José López-Lozano, Pablo Mir, José Marey & Jaime Kulisevsky. (2013) Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial. Journal of Neural Transmission 121:4, pages 357-366.
Crossref
Crossref
Venkatraman Junnotula & Hermes Licea-Perez. (2013) Development and validation of a simple and sensitive method for quantification of levodopa and carbidopa in rat and monkey plasma using derivatization and UPLC–MS/MS. Journal of Chromatography B 926, pages 47-53.
Crossref
Crossref
Zhongping Mao, Ann Hsu, Suneel Gupta & Nishit B. Modi. (2013) Population Pharmacodynamics of IPX066: An Oral Extended‐Release Capsule Formulation of Carbidopa–Levodopa, and Immediate‐Release Carbidopa–Levodopa in Patients With Advanced Parkinson's Disease. The Journal of Clinical Pharmacology 53:5, pages 523-531.
Crossref
Crossref
O.Y. Chao, J.P. Huston, A. von Bothmer & M.E. Pum. (2011) Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exasperates parkinsonian symptoms. Neuroscience 196, pages 228-236.
Crossref
Crossref
F. Bugamelli, C. Marcheselli, E. Barba & M.A. Raggi. (2011) Determination of l-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC–ED. Journal of Pharmaceutical and Biomedical Analysis 54:3, pages 562-567.
Crossref
Crossref
H. Surya Prakash Rao, K. Geetha & M. Kamalraj. (2011) Synthesis of lactones of ortho-tyrosine, DOPA isomers and tryptophan-ortho-tyrosine hybrid amino acids. RSC Advances 1:6, pages 1050.
Crossref
Crossref
David J. Brooks, Spyridon Papapetropoulos, Francois Vandenhende, Davorka Tomic, Ping He, Alex Coppell & Gilmore O'Neill. (2010) An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers. Clinical Neuropharmacology 33:2, pages 55-60.
Crossref
Crossref
Kristiina Haasio. 2010. Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors. Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors
163
189
.
Bai-Yun Zeng, Robert H. Balfour, Mike J. Jackson, Sarah Rose & Peter Jenner. (2009) Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets. Journal of Neural Transmission 117:1, pages 45-51.
Crossref
Crossref